Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.75 USD | -2.90% | -12.81% | -28.10% |
10/05 | UBS Trims Price Target on Evolent Health to $44 From $46, Keeps Buy Rating | MT |
09/05 | Evolent Health Q1 Adjusted Earnings, Revenue Rise; Q2 Revenue Guidance Set, 2024 Revenue Outlook Increased | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.10% | 272.35Cr | |
+5.89% | 3.29TCr | |
+18.09% | 781.69Cr | |
+30.15% | 416.79Cr | |
-18.15% | 141.44Cr | |
-33.33% | 114.84Cr | |
+9.61% | 98Cr | |
-37.56% | 87Cr | |
-26.41% | 83Cr | |
-19.89% | 69Cr |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Cowen Adjusts Price Target on Evolent Health to $59 From $57, Maintains Outperform Rating